Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
Disorders of Hemostasis01:24

Disorders of Hemostasis

699
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
699
Coagulation01:09

Coagulation

4.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

5.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.5K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis.

Journal of hepatology·2026
Same author

Implications of Liver Failure Cutoffs for Mortality Prediction in Hospitalized Cirrhosis Patients: A Multicentric Study.

Gastro hep advances·2026
Same author

Overlap Syndromes and Associated Immunoglobulin-G4-Related Liver Diseases.

Journal of clinical and experimental hepatology·2026
Same author

Fluorescence Lifetime and Smartphone-Enabled Detection of Amyloid-β for Diagnosis and Staging in Alzheimer's Disease.

ACS chemical neuroscience·2026
Same author

Consensus versus Outcome-based Definitions of Acute-on-chronic Liver Failure: Implications for Risk Stratification and Case Identification.

Journal of clinical and translational hepatology·2026
Same author

Shifting epidemiology and disease severity: Rethinking India's hepatitis A strategy in the context of acute liver failure.

Journal of family medicine and primary care·2026

Related Experiment Video

Updated: Jun 4, 2025

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

8.8K

Coagulopathy in acute liver failure.

Akash Roy1, Yogendra Kumar2, Nipun Verma2

  • 1Institute of Gastrosciences and Liver Transplantation, Apollo Multi-speciality Hospitals, Kolkatta, India.

Best Practice & Research. Clinical Gastroenterology
|December 21, 2024
PubMed
Summary

Acute liver failure (ALF) involves severe liver dysfunction and altered mental status. Despite high prothrombin time, bleeding risks in ALF are surprisingly low due to a rebalanced coagulation state.

Keywords:
BleedingCoagulationFulminant hepatic failureViscoelastic hemostatic assays

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

9.9K
Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring
06:11

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring

Published on: May 21, 2017

8.5K

Related Experiment Videos

Last Updated: Jun 4, 2025

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

8.8K
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

9.9K
Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring
06:11

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring

Published on: May 21, 2017

8.5K

Area of Science:

  • Hepatology
  • Hematology
  • Critical Care Medicine

Background:

  • Acute liver failure (ALF) is a critical condition characterized by rapid liver dysfunction and encephalopathy.
  • Coagulopathy, indicated by elevated prothrombin time and international normalized ratio, is a hallmark of ALF.
  • Traditional views associate coagulopathy with high bleeding risks.

Purpose of the Study:

  • To investigate the hemostatic balance in patients with acute liver failure.
  • To re-evaluate the association between coagulopathy markers and actual bleeding risks in ALF.
  • To explore the utility of advanced hemostatic assays in understanding ALF pathophysiology.

Main Methods:

  • Review of existing literature on ALF definitions and hemostatic profiles.
  • Analysis of data from viscoelastic hemostatic assays and thrombin generation assays.
  • Comparison of hemostatic states in ALF with those in cirrhosis.

Main Results:

  • Emerging evidence indicates a rebalanced coagulation state in ALF, mirroring that seen in cirrhosis.
  • Despite elevated coagulation markers, spontaneous and procedural bleeding risks in ALF are unexpectedly low.
  • Viscoelastic and thrombin generation assays corroborate this rebalanced hemostatic profile.

Conclusions:

  • The hemostatic system in ALF is not simply a pro-bleeding state but a complex rebalanced system.
  • Current guidelines for managing coagulopathy in ALF may need revision based on this new understanding.
  • Further research is needed to optimize interventions for bleeding risks in ALF, considering the rebalanced hemostasis.